EU launch plans for ECOVAXXIN® MS

AI SummaryClose X

ECO Animal Health Group plc is progressing its commercial launch strategy for ECOVAXXIN® MS, a poultry vaccine against Mycoplasma synoviae, across the European Union with a phased rollout planned for 2026 and 2027. The company has secured distribution agreements covering over 220 million layer birds annually in the EU's top seven layer-producing countries, leveraging its existing commercial network for Aivlosin®. ECO expects ECOVAXXIN® MS sales to be immediately margin accretive and contribute materially to EBITDA from the 2027/2028 financial year. The launch aims to position ECO as a comprehensive Mycoplasma solutions provider, combining prevention with its treatment product, Aivlosin®.

Disclaimer*

UK 100

Latest directors dealings